FYB.DE
Price:
$23.9
Market Cap:
$422.18M
Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease and ulcerative colitis, which is in the Phase III clinical trial; and FYB203, a biosimilar candidate for Eylea to treat neovascular age-related macular degeneration and other eye diseases that is in Phase III clinical trials. The company is also develo...[Read more]
Industry
Biotechnology
IPO Date
2011-01-04
Stock Exchange
XETRA
Ticker
FYB.DE
According to Formycon AG’s latest financial reports and current stock price. The company's current Enterprise Value is 405.11M. This represents a change of -49.22% compared to the average of 797.81M of the last 4 quarters.
The mean historical Enterprise Value of Formycon AG over the last ten years is 546.94M. The current 405.11M Enterprise Value has changed 7.31% with respect to the historical average. Over the past ten years (40 quarters), FYB.DE's Enterprise Value was at its highest in in the December 2022 quarter at 1.35B. The Enterprise Value was at its lowest in in the January 2009 quarter at 0.
Average
546.94M
Median
424.10M
Minimum
214.39M
Maximum
1.23B
Discovering the peaks and valleys of Formycon AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 136.21%
Maximum Annual Enterprise Value = 1.23B
Minimum Annual Increase = -26.57%
Minimum Annual Enterprise Value = 214.39M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 897.57M | -0.28% |
| 2023 | 900.10M | -26.57% |
| 2022 | 1.23B | 94.04% |
| 2021 | 631.77M | 15.51% |
| 2020 | 546.96M | 84.23% |
| 2019 | 296.88M | 23.94% |
| 2018 | 239.54M | -20.48% |
| 2017 | 301.24M | 40.51% |
| 2016 | 214.39M | -0.33% |
| 2015 | 215.11M | 136.21% |
The current Enterprise Value of Formycon AG (FYB.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.01B
5-year avg
840.45M
10-year avg
546.94M
Formycon AG’s Enterprise Value is less than Verastem, Inc. (502.77M), greater than Zura Bio Limited (122.37M), less than Medios AG (452.48M), greater than Stratec SE (378.04M), greater than Heidelberg Pharma AG (111.07M), less than Newron Pharmaceuticals S.p.A. (455.39M), greater than 4basebio PLC (94.62M), greater than BRAIN Biotech AG (55.67M), greater than M1 Kliniken AG (304.21M), greater than High Tide Inc. (365.89M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 502.77M | $493.39M | |
| 122.37M | $221.07M | |
| 452.48M | $347.90M | |
| 378.04M | $268.04M | |
| 111.07M | $133.80M | |
| 455.39M | $433.15M | |
| 94.62M | $123.10M | |
| 55.67M | $66.20M | |
| 304.21M | $327.87M | |
| 365.89M | $217.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Formycon AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Formycon AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Formycon AG's Enterprise Value?
What is the highest Enterprise Value for Formycon AG (FYB.DE)?
What is the 3-year average Enterprise Value for Formycon AG (FYB.DE)?
What is the 5-year average Enterprise Value for Formycon AG (FYB.DE)?
How does the current Enterprise Value for Formycon AG (FYB.DE) compare to its historical average?